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http://dx.doi.org/10.1016/j.jds.2013.0Abstract Background/purpose: Various toxic products are generated by periodontal patho-
gens. Porphyromonas gingivalis has been found to generate lipopolysaccharide (LPS) that
may potentially affect periodontal health. However, the precise effects of P. gingivalis LPS
on human gingival fibroblasts (GFs) await further investigation.
Materials and methods: Human GFs were cultured and exposed to different concentrations of
P. gingivalis LPS (0.1e10 mg/mL) for 24 hours. Cytotoxicity was analyzed by a 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay. Total ribonucleic acid
(RNA) was isolated and subjected to reverse transcriptase-polymerase chain reaction (RT-
PCR) using specific primer sets. Culture medium was collected for determination of prosta-
glandin E2 (PGE2), PGF2a, and interleukin-8 (IL-8) production by enzyme-linked immunosorbent
assay. ERK1/2 phosphorylation in GFs was evaluated by Western blotting. In some experiments,
U0126 (a MEK/ERK inhibitor) was added to the GFs culture 30 minutes before LPS and culture
medium was also collected for analysis.ntistry and Department of Dentistry, National Taiwan University Medical College and National Taiwan
-Te Street, Taipei, Taiwan.
Science Team, Chang Gung University of Science and Technology, 261, Wen-Hua 1st Road, Kwei-Shan,
gust.edu.tw (M.-C. Chang), jhjeng@ntu.edu.tw (J.-H. Jeng).
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Stimulation of prostanoids and IL-8 production 79Results: P. gingivalis LPS (0.1e10 mg/mL) showed little cytotoxicity and morphologic changes of
GFs. P. gingivalis LPS obviously stimulated the cyclooxygenase-2 (COX-2) and IL-8 messenger
RNA expression of GFs after 24 hours of exposure. Moreover, P. gingivalis LPS induced PGE2,
PGF2a, and IL-8 production in GFs. P. gingivalis LPS also induced ERK1/2 phosphorylation in
GFs. Stimulation of PGE2 production by P. gingivalis LPS was completely attenuated by
U0126, whereas U0126 only partially inhibited the LPS-induced IL-8 production in the same con-
dition.
Conclusion: Our data indicate that P. gingivalis LPS stimulates gene expression of differential
inflammatory mediators (COX-2 and IL-8) as well as prostanoids and IL-8 production in GFs.
These events are associated with MEK/ERK signaling and crucial in the pathogenesis of inflam-
matory periodontal diseases.
Copyright ª 2013, Association for Dental Sciences of the Republic of China. Published by
Elsevier Taiwan LLC. All rights reserved.Introduction
Periodontitis is one of the most common chronic infectious
diseases and is especially prevalent among elderly pop-
ulations. It is a multifactorial disease caused primarily by
microorganisms but significantly modified by the host
response to bacterial invasion. Recent reports on the associ-
ations and potential biologic mechanisms between periodon-
titis and other diseases showed that periodontal diseases may
be a risk factor of coronary heart disease, atherosclerosis, and
cardiovascular diseases.1e3 It means that the patient with
periodontitis could be challenging to treat and treatment
plans should include local and systemic considerations.
According to bacteriologic studies, Porphyromonas gingi-
valis has been demonstrated to be closely associatedwith the
onset and progression of adult periodontitis.4,5 P. gingivalis
expresses a variety of pathogenic factors, including micro-
structures such as fimbriae, lipopolysaccharide (LPS), and
flagella, as well as gingipain and endotoxin.6 Previous in vitro
experiments have shown that fimbriae and LPS of P. gingivalis
may stimulate gingival epithelial cells to express a large
amount of inflammatory cytokines, such as interleukin (IL)-
1b, IL-6, IL-8 and tumor necrosis factor-a (TNF-a), as well as
to produce matrix metalloproteinases (MMP-1, -8, -9, -13).7,8
The inflammatory factorsmaydestroy tissue integrity, so that
the bacteria can access deeper tissue. They are also related
to the severity of periodontitis.9 The fimbriae of P. gingivalis
plays an important role in bacterial invasion into the cells and
its pathogenic ability. In humanmonocytes, the fimbriae of P.
gingivalis induces IL-6 production via TLR2, CD14, and
CD11a/CD18 molecules, and it is also related to nuclear
factor kappa-light-chain-enhancer of activated B cells (NF-
kB) activation.10 Moreover, the protease expressed by P.
gingivalis, for example, gingipain, breaks down cytokines
produced by the host, such as IL-6, IL-8, IL-12, and TNF-a and
suppresses the activation of the immune response. The ex-
periments in rats also showed that P. gingivalis gingipain in-
creases epithelial MMP-3 and MMP-8 expression, and affects
the gingival metabolism and repair.11
In periodontal tissues, human gingival fibroblasts (GFs)
are the most abundant cells and have the ability to secrete
inflammatory cytokines such as IL-8 and prostaglandins such
as PGE2when they are activatedwith stimuli.
12,13 IL-8 acts as
a chemoattractant for neutrophils and can activate these
cells.12 In addition, PGE2 plays important roles in thepathogenesis of periodontal diseases. It is associated with
attachment loss and is a powerful stimulator of bone
resorption.13 As the inflammation begins, cyclooxygenase-2
(COX-2) is induced by a variety of cytokines, growth fac-
tors, and LPS, and consequently converts arachidonic acid to
prostaglandins.14 Therefore, the levels of prostaglandins
including PGE2 in inflamed gingival tissues are enhanced.
15
PGF2a as well as PGE2 could be detected in higher levels in
periodontal lesions. It might involve in connective tissue
degradation and bone resorption.16 However, more infor-
mation is necessary for our understanding the role of PGF2a
in the periodontal pathophysiology.
It has been reported that GFs produce a number of
proinflammatory cytokines such as IL-1, IL-6, and IL-8 upon
stimulation by P. gingivalis LPS.12 However, the precise ef-
fects of P. gingivalis LPS on GFs await further investigation.
In this study, we examined COX-2 and IL-8 gene expression,
prostanoids, and IL-8 production in GFs after P. gingivalis LPS
stimulation. The results of our study may facilitate our un-
derstanding of the pathogenesis of periodontitis.
Materials and methods
Materials
All cell culture materials were purchased from Gibco Lab-
oratories (Life Technologies, Grand Island, NY, USA). 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide
(MTT), was obtained from Sigma (Sigma Chemical Company,
St. Louis, MO, USA). P. gingivalis LPS was obtained from
InvivoGen (San Diego, CA, USA). PCR primers were synthe-
sized from Genemed Biotechnologies, Inc (San Francisco,
CA, USA). PGE2 and PGF2a enzyme-linked immunosorbent
assay (ELISA) kits were from Cayman Chemical Company
(Ann Arbor, MI, USA). IL-8 ELISA kits were from PeproTech
Inc. (Rocky Hill, NJ, USA).
Culture of human gingival fibroblasts
Gingival tissues were obtained during crown-lengthening
procedures by the approval of the Ethics Committee,
National Taiwan University Hospital and the informed con-
sent of the patients. GFs were cultured by a tissue explant
technique as described previously and cultured in
80 Y.-L. Tsai et alDulbecco’s Modified Eagle’s Medium (DMEM) with 10% fetal
bovine serum (FBS).17e19
Effects of P. gingivalis LPS on the PGE2, PGF2a, and
IL-8 production of GFs
Briefly, 1  105 of GFs were inoculated onto 24-well culture
plates. After 24 hours, the medium was changed to contain
different concentrations of P. gingivalis LPS (0.1e10 mg/
mL). Cells were further cultured for 24 hours. Culture
medium was collected for PGE2, PGF2a, and IL-8 production
by ELISA.20 Viable GFs were estimated by MTT assay as
described previously.20
In some experiments, U0126 (a MEK/ERK signaling inhib-
itor) was added 30 minutes prior to the addition of P. gin-
givalis LPS and then coincubated for 24 hours. Culture
medium was collected for analysis of PGE2 and IL-8 by ELISA.
Effects of P. gingivalis LPS on COX-2 and IL-8 mRNA
expression of GFs
RNA isolation
In brief, 2  106 GFs were inoculated onto 10-cm culture
dishes. After 24 hours of cell attachment, they were
exposed to different concentrations of P. gingivalis LPS
(0.1e10 mg/mL) for 24 hours. Total RNA was isolated with
the RNA isolation kit.21
Reverse transcriptaseepolymerase chain reaction
Reverse transcriptaseepolymerase chain reaction (RT-PCR)
was performed using specific primers as described previ-
ously.20,21 Briefly, 3 mg of denatured total RNA was reverse
transcribed in a total volume of 44.5 mL reaction mixture
containing 4 mL of random primer (500 mg/mL), 8 mL of
deoxyribonucleotide triphosphate (dNTP) (2.5 mM), 4.5 mL
of 10 RT buffer, 1 mL of RNase inhibitor (40 U/mL), and
0.5 mL of RT (21 U/mL) at 42C for 90 minutes. Then, we
used 4 mL of complementary deoxyribonucleic acid (cDNA)
for PCR amplification in a reaction volume of 50 mL
comprising 5 mL of 10 Super Taq buffer, 4 mL of dNTP
(2.5 mM), 1 mL of each specific primer, and 0.2 mL of Super
Taq enzyme (2 U/mL). The PCR reaction was conducted at
94C for 5 minutes for the first cycle, and then further
amplified for 15e30 cycles at 94C for 1 minutes, 55C for
1 minute, and then 72C for 2 minutes with a thermal cycler
(Perkin Elmer 4800, PE Applied Biosystems, Foster City, CA,
USA). Finally, the reaction was terminated at 72C for an
additional 10 min. The specific primer pairs for COX-2, IL-8,
and b-actin were used as described previously.20,21 The
PCR-amplified products were subjected to 1.8% agarose gel
electrophoresis and then the gels were stained with
ethidium bromide and photographed. The amount of
amplified DNA product that is linear with respect to the
input RNA was used for picture and data presentation. The
amplification of the b-actin gene was used as a control.
Stimulation of ERK phosphorylation by P. gingivalis
LPS in GFs
Briefly, GFs (2  106 cells/10-cm dish) were exposed to
P. gingivalis LPS (5 mg/mL) for 2.5, 5, 10, 30, 60, and120 minutes. Cells were then washed with phosphate-
buffered saline, and then dissolved in 180 mL lysis buffer
(10 mM Tris-HCl pH 7, 140 mM NaCl, 3 mM MgCl2, 0.5% NP-
40, 2 mM phenylmethylsulfonyl fluoride, 1% aprotinin, and
5 mM dithiothreitol). The cell lysates were transferred to
centrifuge tubes, and the insoluble material was pellet
by centrifugation. Protein concentrations were measured
by BioRad protein assay kits (BioRad Laboratories, Hercu-
les, CA, USA). Next, equal amounts of proteins were sub-
jected to 12% polyacrylamide gel electrophoresis and
transferred to polyvinylidene fluoride (PVDF) membrane.
The membrane was blocked at room temperature in a
blocking reagent and then incubated with antibodies
against human p-ERK1/2 and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) for 3 hours. The primary anti-
bodies were detected with horseradish peroxidase (HRP)-
conjugated secondary antibodies. The immunoreactive
bands were finally seen on radiographs using enhanced
chemiluminescence reagent.20,21
Statistical analysis
At least four or more separate experiments were conducted
with similar results. Results were analyzed by paired t-test.
A P value <0.05 was considered to have significant differ-
ence between two groups.
Results
All GFs displayed elongated, spindle-shaped, or fibroblast-
like morphology. There was no distinct difference in the
morphology of GFs after exposure to different concentra-
tions of P. gingivalis LPS (0.1e5 mg/mL) (Fig. 1A and B).
P. gingivalis LPS (0.1e10 mg/mL) also showed little cyto-
toxicity to GFs as analyzed by MTT assay (Fig. 1C).
P. gingivalis LPS (1e5 mg/mL) obviously stimulated the
COX-2 and IL-8 mRNA expression of GFs after 24 hours of
exposure (Fig. 2). The gene expression of IL-8 was raised
with an increasing concentration of P. gingivalis LPS
evidently, and the elevation was apparent after stimulation
by 5 mg/mL of P. gingivalis LPS.
Accordingly, P. gingivalis LPS induced PGE2, and PGF2a
production was elevated with increased P. gingivalis LPS
concentration (Fig. 3A and B). At concentrations of 1 and
5 mg/mL, P. gingivalis LPS elevated the PGE2 production to
2.36- and 3.58-fold of control, respectively (Fig. 3A).
Similarly, P. gingivalis LPS also increased the PGF2a pro-
duction of GFs at a concentration of 10 mg/mL (Fig. 3B). The
production of IL-8 by GFs was also stimulated by P. gingi-
valis LPS to 2.29- and 3.40-fold of control at concentrations
of 5 and 10 mg/mL (Fig. 3C).
As shown in Fig. 4, 5 mg/mL P. gingivalis LPS stimulated
the phosphorylation of ERK1/2 of GFs following 10 minutes
of exposure. The ERK phosphorylation in GFs became more
evident after 30e120 minutes of exposure.
In addition, the P. gingivalis LPS-induced PGE2 produc-
tion of GFs was completely inhibited by 1 and 10 mM U0126
(Fig. 5A). In the same experimental condition, U0126 (1 and
10 mM) only partially attenuated the P. gingivalis LPS-
induced IL-8 production in GFs, with 31% and 47% of inhi-
bition, respectively (Fig. 5B).
Figure 1 Effect of P. gingivalis LPS on the morphology and
cytotoxicity of GFs. Morphology of (A) untreated GFs, and (B)
GFs treated by 5 mg/mL of P. gingivalis LPS for 24 hours. (100,
original magnification). (C) Cytotoxicity of P. gingivalis LPS
(0.1e10 mg/mL) on GFs as analyzed by MTT assay. Results are
expressed as a percentage of the controls (n Z 10).
Figure 2 Stimulation of cyclooxygenase-2 (COX-2) and
interleukin-8 (IL-8) messenger RNA expression of GFs after
exposure to P. gingivalis LPS (0.1e10 mg/mL) for 24 hours. One
representative polymerase chain reaction picture is shown.
The expression of b-actin was used as a control.
MW Z molecular weight marker.
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LPS is the major macromolecule on the outer membrane of
Gram-negative bacteria. It could be recognized by host as a
foreign molecule and cause a series of immune responses.22
It has been clinically and histologically demonstrated that
LPS can penetrate gingival crevicular epithelium and the
amount of LPS is correlated with gingival inflammation.13
The special structure is an important virulence factor of
P. gingivalis as mentioned previously. P. gingivalis LPS has
been confirmed to be chemically and structurally different
from the well-studied enterobacterial LPS. In addition, the
biologic activity of P. gingivalis LPS is relatively low, which
may reflect the organisms’ ability to colonize and grow in
tissue that the host cannot recognize.6 This characteristic
of P. gingivalis LPS may play an important role in disrupting
the oral immune homeostasis.22 P. gingivalis LPS has been
shown to inhibit the mitogenic response of periodontal
ligament fibroblasts to platelet-derived growth factor.23
However, in this study P. gingivalis LPS showed little cyto-
toxicity and induced no marked morphologic change of GFs.
This finding indicates that cellular response to P. gingivalis
LPS may vary among cells.
In identical cell culture systems of human GFs, P. gin-
givalis LPS is active in the induction of cytokines such as IL-
1b, IL-6, and IL-8, whereas enterobacterial LPS is not. The
reason for this different activation may be due to the dif-
ference of the structure of LPS molecules or the difference
in their receptors on the cells.6 In this study, P. gingivalis
LPS significantly increases the PGE2 and PGF2a production,
and COX-2 expression at concentrations higher than 5 mg/
mL. PGE2 and PGF2a are two major inflammatory mediators.
An increase in PGE2 level may induce inflammatory re-
sponses such as vasodilatation, inhibition of lymphocyte
proliferation, stimulation of neutrophil infiltration, and
increase in vascular permeability and bone resorption.24
PGF2a is also implicated in the induction of tissue inflam-
mation and cardiovascular and rheumatic diseases.25 It has
been demonstrated that LPS induces the expression of COX-
2 in different types of cells, including human peripheral
blood monocytes, human endothelial cells, rat mesangial
cells, and mononuclear inflammatory cells in inflamed
gingiva.26 In human peripheral blood monocytes and GFs,
Figure 3 (A) Stimulation of PGE2 production in gingival fi-
broblasts (GFs) by P. gingivalis LPS (n Z 5). (B) Stimulation of
PGF2a production in GFs by P. gingivalis LPS (n Z 4). (C)
Stimulation of IL-8 production in GFs by P. gingivalis LPS
(n Z 7). All the results are expressed as mean  standard
error. * Significant difference when compared with control.
Figure 4 Induction of the ERK phosphorylation in GFs by
5 mg/mL P. gingivalis LPS in different exposure periods. One
representative Western blot picture is shown. Expression of
glyceraldehyde 3-phosphate dehydrogenase was used as a
control.
Figure 5 Effect of U0126 on P. gingivalis LPS-induced PGE2
and IL-8 production in GFs. (A) U0126 inhibited the P. gingivalis
LPS-induced prostaglandin E2 (PGE2) in GFs (n Z 5). (B) U0126
partially inhibited the P. gingivalis LPS-induced IL-8 production
in GFs (nZ 7). Results are expressed as mean  standard error.
* Statistically significant difference when compared with un-
treated control group. # Statistically significant difference
when comparing these groups with 5 mg/mL P. gingivalis LPS
solely group.
82 Y.-L. Tsai et alCOX-2 was also proved to be induced in response to P.
gingivalis LPS and the elicited COX-2 mainly involved in
PGE2 production.
13,26 This may partly explain why PGE2 and
PGF2a levels are elevated in inflamed periodontal tissues
16
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processes. Moreover, we found that P. gingivalis LPS may
activate ERK1/2 phosphorylation and stimulation of PGE2
production in GFs by P. gingivalis LPS and is completely
inhibited by U0126 (a MEK/ERK inhibitor). This finding re-
veals that P. gingivalis LPS may stimulate prostanoids (such
as PGE2 and PGF2a) production mainly through MEK/ERK
activation and COX-2 expression.
IL-8 is an important inflammatory cytokine that induces
chemotactic and stimulatory responses to neutrophils.
Under stimulation by IL-8, the expression of complement
receptor CR-1 and cell adhesion molecules CD11b/CD18
glycoprotein on the neutrophils are induced, leading to an
increased adhesion of neutrophils to endothelial cells. IL-8
is also chemotactic for T lymphocytes and basophils and is
capable of stimulating IL-3-primed basophils to release
histamine and leukotrienes. It has been reported that IL-8
could be induced by LPS in monocytes, endothelial cells,
and neutrophils.27 In fibroblasts, however, LPS from
enterobacteria failed to induce the production of IL-8.
Previous studies have shown that LPS of Bacteroides
including P. gingivalis directly stimulated GFs to produce IL-
827 and the ability to induce IL-8 in fibroblasts appeared to
be peculiar to Bacteroides LPS, which may be related to the
etiology of human periodontal diseases.27 A previous study
also shows that PGF2a and IL-8 are significantly elevated
during inflammation of human and rat dental pulp. PGF2a
might play a role in the pathogenesis of pulpal inflammation
via induction of IL-8 production.20 Different methods were
used in this study to verify IL-8 induction in GFs by P. gin-
givalis LPS stimulation. Our results showed that even in low
concentration, P. gingivalis LPS stimulated GFs to induce IL-
8 gene expression and IL-8 production. Interestingly,
P. gingivalis LPS induced-IL-8 production in GFs is partly
inhibited by U0126, suggesting its association with MEK/ERK
signaling. However, additional signaling pathways may be
present that should be studied in greater detail in the
future.
In conclusion, the results of this study indicate that P.
gingivalis LPS may activate MEK/ERK signaling to differen-
tially regulate inflammatory genes (COX-2 and IL-8)
expression as well as PGE2, PGF2a, and IL-8 production.
These events can be crucial in the inflammation and repair
processes of periodontal diseases.
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